期刊
BIOLOGICS-TARGETS & THERAPY
卷 11, 期 -, 页码 107-114出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/BTT.S136011
关键词
Alzheimer's disease; acetylcholinesterase; butyryl cholinesterase; neurodegenerative; Spondias mombin
Spondias mombin has been used in traditional medicine for the management of several diseases, including memory loss. This study aimed to evaluate the cholinesterase inhibitory activity of the methanol extract of the leaves and its derived fractions, as well as carry out detailed phytochemical investigations leading to the isolation and characterization of bioactive compounds from the plant. The acetyl cholinesterase (AChE) and butyryl cholinesterase (BUChE) inhibitory activities were evaluated by colorimetric and thin-layer chromatography bioautographic assay techniques. The ethyl acetate fraction was most active against both enzymes, with percentage inhibition of 58.10 +/- 1.08% and 52.66 +/- 1.34% against AChE and BUChE, respectively. Three compounds, namely, botulin, campesterol and phytol, with IC 50 of 0.88 mu g/mL (AChE), 4.67 mu g/mL (BuChE); 1.89 mu g/mL (AChE), 4.08 mu g/mL (BuChE) and 12.51 mu g/mL (AChE), 23.89 mu g/mL (BuChE), respectively, were isolated from the supernatant of the ethyl acetate fraction. The isolated cholinesterase inhibitory compounds correlate with the known memory-enhancing property of the plant and thus support one of its uses in ethnomedicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据